The document summarizes how the Innovative Medicines Initiative (IMI) supports collaborative research projects. IMI provides funding from the EU and contributions from pharmaceutical companies. Projects involve a range of participants, including academia, small businesses, patient groups, and regulators. The document outlines IMI's rules around funding, intellectual property, and participation requirements.